Evidence for chemotherapy-induced cognitive changes comes from studies that have used neuropsychological testing, imaging (structural and functional magnetic resonance imaging (MRI) and positron ...

Results of 3 trials revealed that omitting transplant did not impact progression or survival outcomes for pediatric, ...

Department of Cell Toxicology, Helmholtz Centre for Environmental Research−UFZ, Permoserstr. 15, Leipzig 04318, Germany ...

A risk model comprised of 18 mitochondria-related genes (MRGs) offers the potential to provide personalized prognostic assessment and to guide treatment for patients with diffuse large B-cell lymphoma ...

Bristol-Myers Squibb was founded in 1858 and has grown to be one of today's leading global pharmaceutical companies. For over 150 years, Bristol-Myers Squibb (BMS) has been committed to "discover ...

During the past 20 years, the advent of neoadjuvant, primary, and adjuvant concurrent chemoradiotherapy has improved cancer care dramatically. Significant contributions have been made by ...

Background A growing evidence base supports the use of autologous haematopoietic stem cell transplantation (aHSCT) for treatment of relapsing-remitting multiple sclerosis (RRMS), but it has not yet ...